PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Total alkaloids of F. cirrhosa alleviated bleomycin-induced inflammation and pulmonary fibrosis in rat models [PMID: 38187805]
F. cirrhosa alleviated inflammatory progression and suppressed M1 polarization of macrophages in a COPD-like mouse model [PMID: 39284286]
Six isosteroidal alkaloids reduced ROS production and promoted Nrf2 expression in RAW264.7 macrophages exposed to cigarette smoke extract [PMID: 31760067]
In silico assessment and network pharmacology suggest potential for suppressing breast carcinoma [PMID: 37948293]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35176308 (2022) — Cirrhosinones A-H, 24-hydroxy cevanine-type alkaloids from Fritillariacirrhosa. · Phytochemistry
- 2.PMID: 36924862 (2023) — Antiplasmodial activity of the bulbs of Fritillaria cirrhosa D.Don (Syn: Fritillaria roylei Hook.): UPLC-IM-Q-TOF-MS/MS-based biochemometric approach for the identification of marker compounds. · Journal of ethnopharmacology
- 3.PMID: 29751123 (2018) — High altitude species, high profits: Can the trade in wild harvested Fritillaria cirrhosa (Liliaceae) be sustained? · Journal of ethnopharmacology
- 4.PMID: 38927666 (2024) — Phylogeny, Genetic Diversity and Population Structure of Fritillaria cirrhosa and Its Relatives Based on Chloroplast Genome Data. · Genes
- 5.PMID: 37107505